The impact of recent screening recommendations on prostate cancer screening in a large health care system

The Journal of Urology
Afshin AslaniRobert Abouassaly

Abstract

The United States Preventive Services Task Force recently recommended against routine prostate cancer screening, stating that the risks of screening outweigh the benefits. We determined the impact of this recommendation on prostate cancer screening in a large health system. We obtained data on all screening prostate specific antigen tests performed at University Hospitals Case Medical Center and affiliated hospitals in northeastern Ohio from January 2008 to December 2012. We examined the total number of prostate specific antigen tests ordered with time and adjusted for patient volume by fitting a regression line. The overall trend was examined and stratified by location (urban, suburban or rural), patient age and provider type (primary care or urology). A total of 43,498 screening prostate specific antigen tests were performed from January 2008 to December 2012. Most tests were ordered by specialists in internal medicine (64.9%), followed by family medicine (23.7%), urology (6.1%) and hematology/oncology (1.3%). Prostate specific antigen screening increased with time until March 2009, when initial screening trials were published. Prostate specific antigen testing then decreased significantly and continued to decrease after the ...Continue Reading

References

Nov 8, 1995·JAMA : the Journal of the American Medical Association·S J JacobsenM M Lieber
Feb 15, 1995·JAMA : the Journal of the American Medical Association·A L PotoskyB S Kramer
Mar 20, 2009·The New England Journal of Medicine·Gerald L AndrioleUNKNOWN PLCO Project Team
Mar 20, 2009·The New England Journal of Medicine·Fritz H SchröderUNKNOWN ERSPC Investigators
Sep 29, 2009·The Journal of Urology·Kirsten L GreenePeter Carroll
Mar 2, 2011·Journal of the National Cancer Institute·Steven B ZeliadtDaniel W Lin
Oct 28, 2011·The New England Journal of Medicine·Mary F McNaughton-Collins, Michael J Barry
Apr 6, 2012·World Journal of Urology·Otis W Brawley
Jul 18, 2012·Annals of Internal Medicine·Virginia A Moyer, UNKNOWN U.S. Preventive Services Task Force
Dec 19, 2012·The Journal of Urology·Kirsten L GreeneUNKNOWN American Urological Association
Mar 6, 2013·Journal of the National Cancer Institute·James S GoodwinYong-Fang Kuo
Apr 10, 2013·Annals of Internal Medicine·Amir QaseemUNKNOWN Clinical Guidelines Committee of the American College of Physicians
May 11, 2013·The Journal of Urology·H Ballentine CarterAnthony L Zietman
Jun 4, 2013·The Medical Journal of Australia·Andrew J MartinJon D Emery

❮ Previous
Next ❯

Citations

Oct 16, 2015·International Journal of Clinical Practice·M T RosenbergE David Crawford
Jun 30, 2015·Clinical Genitourinary Cancer·Vinayak MuralidharPaul L Nguyen
Feb 26, 2015·SpringerPlus·Weranja Kb RanasingheNathan Lawrentschuk
Sep 1, 2015·The Surgical Clinics of North America·William Tabayoyong, Robert Abouassaly
Apr 18, 2016·Medicina clínica·Jose Maria Abascal JunqueraLluis Cecchini Rosell
Mar 31, 2015·Cancer Causes & Control : CCC·F EisingerJ Viguier
Mar 25, 2014·The Journal of Urology·Michael H Hsieh, Max V Meng
Dec 21, 2016·Nature Reviews. Urology·Katherine FleshnerMonique J Roobol
Jun 10, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael W DrazerScott E Eggener
Oct 7, 2018·Journal of the American Geriatrics Society·Julie BynumJonathan Skinner
May 30, 2017·The Journal of Urology·Daniel J LeeDaniel A Barocas
May 1, 2019·International Braz J Urol : Official Journal of the Brazilian Society of Urology·Fernando Antônio Glasner da Rocha AraújoUbirajara de Oliveira Barroso
May 24, 2019·Clinical Chemistry and Laboratory Medicine : CCLM·Xavier FilellaNuria Giménez
May 14, 2014·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Julia L MarcusMichael J Silverberg
Aug 17, 2020·Journal of the National Cancer Institute·Daniel J BeckerDanil V Makarov
Dec 10, 2015·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Richard M HoffmanCharles L Wiggins
Apr 30, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B A MahalP L Nguyen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.